These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29295803)

  • 1. Differential effects on sodium current impairments by distinct SCN1A mutations in GABAergic neurons derived from Dravet syndrome patients.
    Kim HW; Quan Z; Kim YB; Cheong E; Kim HD; Cho M; Jang J; Yoo YR; Lee JS; Kim JH; Kim YI; Kim DS; Kang HC
    Brain Dev; 2018 Apr; 40(4):287-298. PubMed ID: 29295803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current.
    Schutte RJ; Schutte SS; Algara J; Barragan EV; Gilligan J; Staber C; Savva YA; Smith MA; Reenan R; O'Dowd DK
    J Neurophysiol; 2014 Aug; 112(4):903-12. PubMed ID: 24805083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological Alterations of Pyramidal Cells and Interneurons of the CA1 Region of the Hippocampus in a Novel Mouse Model of Dravet Syndrome.
    Dyment DA; Schock SC; Deloughery K; Tran MH; Ure K; Nutter LMJ; Creighton A; Yuan J; Banderali U; Comas T; Baumann E; Jezierski A; ; Boycott KM; Mackenzie AE; Martina M
    Genetics; 2020 Aug; 215(4):1055-1066. PubMed ID: 32554600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomes of Dravet syndrome iPSC derived GABAergic cells reveal dysregulated pathways for chromatin remodeling and neurodevelopment.
    Schuster J; Laan L; Klar J; Jin Z; Huss M; Korol S; Noraddin FH; Sobol M; Birnir B; Dahl N
    Neurobiol Dis; 2019 Dec; 132():104583. PubMed ID: 31445158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome.
    Tiraboschi E; Martina S; van der Ent W; Grzyb K; Gawel K; Cordero-Maldonado ML; Poovathingal SK; Heintz S; Satheesh SV; Brattespe J; Xu J; Suster M; Skupin A; Esguerra CV
    Epilepsia; 2020 Mar; 61(3):549-560. PubMed ID: 32096222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of Sharp-Wave Ripples in a Murine Model of Dravet Syndrome.
    Cheah CS; Lundstrom BN; Catterall WA; Oakley JC
    J Neurosci; 2019 Nov; 39(46):9251-9260. PubMed ID: 31537705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dravet syndrome patient-derived neurons suggest a novel epilepsy mechanism.
    Liu Y; Lopez-Santiago LF; Yuan Y; Jones JM; Zhang H; O'Malley HA; Patino GA; O'Brien JE; Rusconi R; Gupta A; Thompson RC; Natowicz MR; Meisler MH; Isom LL; Parent JM
    Ann Neurol; 2013 Jul; 74(1):128-39. PubMed ID: 23821540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of isogenic iPSCs from an individual with SCN1A mutation mosaicism as a model for investigating neurocognitive impairment in Dravet syndrome.
    Maeda H; Chiyonobu T; Yoshida M; Yamashita S; Zuiki M; Kidowaki S; Isoda K; Yamakawa K; Morimoto M; Nakahata T; Saito MK; Hosoi H
    J Hum Genet; 2016 Jun; 61(6):565-9. PubMed ID: 26841829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human Dravet syndrome model from patient induced pluripotent stem cells.
    Higurashi N; Uchida T; Lossin C; Misumi Y; Okada Y; Akamatsu W; Imaizumi Y; Zhang B; Nabeshima K; Mori MX; Katsurabayashi S; Shirasaka Y; Okano H; Hirose S
    Mol Brain; 2013 May; 6():19. PubMed ID: 23639079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients.
    Sun Y; Paşca SP; Portmann T; Goold C; Worringer KA; Guan W; Chan KC; Gai H; Vogt D; Chen YJ; Mao R; Chan K; Rubenstein JL; Madison DV; Hallmayer J; Froehlich-Santino WM; Bernstein JA; Dolmetsch RE
    Elife; 2016 Jul; 5():. PubMed ID: 27458797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential expression of SCN1A in GABAergic neurons improves survival and epileptic phenotype in a mouse model of Dravet syndrome.
    Ricobaraza A; Bunuales M; Gonzalez-Aparicio M; Fadila S; Rubinstein M; Vides-Urrestarazu I; Banderas J; Sola-Sevilla N; Sanchez-Carpintero R; Lanciego JL; Roda E; Honrubia A; Arnaiz P; Hernandez-Alcoceba R
    J Mol Med (Berl); 2023 Dec; 101(12):1587-1601. PubMed ID: 37819378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep impairment and reduced interneuron excitability in a mouse model of Dravet Syndrome.
    Kalume F; Oakley JC; Westenbroek RE; Gile J; de la Iglesia HO; Scheuer T; Catterall WA
    Neurobiol Dis; 2015 May; 77():141-54. PubMed ID: 25766678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and structural deficits of the dentate gyrus network coincide with emerging spontaneous seizures in an Scn1a mutant Dravet Syndrome model during development.
    Tsai MS; Lee ML; Chang CY; Fan HH; Yu IS; Chen YT; You JY; Chen CY; Chang FC; Hsiao JH; Khorkova O; Liou HH; Yanagawa Y; Lee LJ; Lin SW
    Neurobiol Dis; 2015 May; 77():35-48. PubMed ID: 25725421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two mild cases of Dravet syndrome with truncating mutation of SCN1A.
    Takaori T; Kumakura A; Ishii A; Hirose S; Hata D
    Brain Dev; 2017 Jan; 39(1):72-74. PubMed ID: 27544716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndrome.
    Tai C; Abe Y; Westenbroek RE; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(30):E3139-48. PubMed ID: 25024183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9 facilitates investigation of neural circuit disease using human iPSCs: mechanism of epilepsy caused by an SCN1A loss-of-function mutation.
    Liu J; Gao C; Chen W; Ma W; Li X; Shi Y; Zhang H; Zhang L; Long Y; Xu H; Guo X; Deng S; Yan X; Yu D; Pan G; Chen Y; Lai L; Liao W; Li Z
    Transl Psychiatry; 2016 Jan; 6(1):e703. PubMed ID: 26731440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ndnf Interneuron Excitability Is Spared in a Mouse Model of Dravet Syndrome.
    Liebergall SR; Goldberg EM
    J Neurosci; 2024 Apr; 44(17):. PubMed ID: 38443186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo, in vitro and in silico correlations of four de novo SCN1A missense mutations.
    Nissenkorn A; Almog Y; Adler I; Safrin M; Brusel M; Marom M; Bercovich S; Yakubovich D; Tzadok M; Ben-Zeev B; Rubinstein M
    PLoS One; 2019; 14(2):e0211901. PubMed ID: 30735520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.
    Colasante G; Lignani G; Brusco S; Di Berardino C; Carpenter J; Giannelli S; Valassina N; Bido S; Ricci R; Castoldi V; Marenna S; Church T; Massimino L; Morabito G; Benfenati F; Schorge S; Leocani L; Kullmann DM; Broccoli V
    Mol Ther; 2020 Jan; 28(1):235-253. PubMed ID: 31607539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A selective Na
    Chow CY; Chin YKY; Ma L; Undheim EAB; Herzig V; King GF
    Biochem Pharmacol; 2020 Nov; 181():113991. PubMed ID: 32335140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.